Preview: Summit Therapeutics's Earnings

Summit Therapeutics (NASDAQ:SMMT) is set to give its latest quarterly earnings report on Wednesday, 2024-10-30. Here's what investors need to know before the announcement.

Analysts estimate that Summit Therapeutics will report an earnings per share (EPS) of $-0.07.

Summit Therapeutics bulls will hope to hear the company announce they've not only beaten ...